Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03481283 · ClinicalTrials.gov registry record
A Causative Role for Amylin in Diabetic Peripheral Neuropathy
A clinical trial of Peripheral Neuropathy and Type2 Diabetes, sponsored by Zabeen Mahuwala, MD.
- Recruiting
- Registry status
- 40
- Enrollment target
- 2
- Study locations
NCT03481283 is a study of Peripheral Neuropathy and Type2 Diabetes that is actively recruiting participants, run by Zabeen Mahuwala, MD. The registered enrollment target is 40 participants, below the 79-participant average among 27 other Peripheral Neuropathy trials with a reported enrollment target (49% lower). The trial reports 2 study locations across 1 state.
The verdict
NCT03481283, a study of Peripheral Neuropathy and Type2 Diabetes, is actively recruiting participants, sponsored by Zabeen Mahuwala, MD.
- RECRUITING
- Registry status
- 40 participants
- Enrollment target
- 2
- Study locations
Study Summary
Three pieces of information lead to the basis for this study: 1. Individuals with Type-2 diabetes commonly develop peripheral neuropathy. 2. Increased production of the hormone amylin occurs in individuals who have Type-2 diabetes. 3. Aggregations of amylin was found in the peripheral vasculature of rats that overexpressed human amylin. The purpose of this study is to determine whether a correlation exists between the amount of amylin present in the upper extremities of human subjects with Type-2 diabetes and the extent to which symptoms of peripheral neuropathy are expressed in those subjects. The investigators will be testing this by initially collecting blood and skin biopsy samples from subjects, followed by measuring patient sensation and pain responses to heat, cold, and pressure in the upper extremities.
Conditions Studied
Study Locations (2)
Kentucky
- UK Robert Straus Behavioral Science Laboratory - Lexington
- University of Kentucky - Kentucky Neuroscience Institute - Lexington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2018-02-05 |
| Est. Completion | 2029-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03481283
The ClinicalTrials.gov registry entry for NCT03481283 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 79-participant average among 27 other Peripheral Neuropathy trials with a reported enrollment target (49% lower). The listed sponsor is Zabeen Mahuwala, MD, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Peripheral Neuropathy appearing as the primary indexed condition, and to 0 interventions.
NCT03481283 reports 2 study locations spanning 1 distinct geographic area - top geographies include Kentucky.
Frequently Asked Questions
What is clinical trial NCT03481283 about?
NCT03481283 is a clinical study titled "A Causative Role for Amylin in Diabetic Peripheral Neuropathy". Three pieces of information lead to the basis for this study: 1. Individuals with Type-2 diabetes commonly develop peripheral neuropathy. 2. Increased production of the hormone amylin occurs in individuals who have Type-2 diabetes. 3. Aggregations of amylin was found in the peripheral vasculature o...
What is the current status of trial NCT03481283?
This trial is currently recruiting. The enrollment target is 40 participants. The study started on 2018-02-05. Estimated completion is 2029-01.
What conditions does trial NCT03481283 study?
This clinical trial studies the following conditions: Peripheral Neuropathy, Type2 Diabetes.
Who is sponsoring clinical trial NCT03481283?
This trial is sponsored by Zabeen Mahuwala, MD, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03481283 being conducted?
This trial has 2 study locations across Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Peripheral Neuropathy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Prospective Natural History and Outcome Measure Discovery Study of Charcot-Marie-Tooth Disease, Type 4J
RECRUITING
-
Innovative Treatment of Chemotherapy-Induced Painful Peripheral Neuropathy in Adolescents and Young Adults With Cancer: A Two Arm Pilot Study
RECRUITING · NA
-
Replexa+ Shortwave Diathermy Device for Patients Diagnosed With Peripheral Artery Disease and Peripheral Neuropathy
RECRUITING · NA
-
DoD AtMS for Posttraumatic Peripheral Neuropathic Pain
RECRUITING · NA
-
Intermittent Dosing of Dorsal Root Ganglion Stimulation as an Alternate Paradigm to Continuous Low-Frequency Therapy
RECRUITING · NA
-
Investigational Use of Neuromuscular Ultrasound
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.